Electrical Prescriptions (ElectRx)

Awarded Award Notice Posted

Solicitation number
DARPA-BAA-15-06
Agency
Defense Advanced Research Projects Agency Department of Defense
Awarded
to Massachusetts Institute Of Technology
Set-aside
No set-aside

Opportunity facts

Contract number
HR0011-15-C-0155 Federal contract award
NAICS code
541711 Research and Development in Biotechnology
PSC
Not on record

Notice details come from SAM.gov. Updated .

Notice text

4 versions

Update #4 · Latest ·

Added: Oct 08, 2015 9:55 am Competitively awarded basic research and development contract with goals, objectives, specifications that will attempt to prove the scientific or engineering concepts in question, with cost estimates that are insufficient to permit use of a fixed price contract. Also, the contract will not mature sufficiently to transition to a firm fixed price contract while the program is managed at DARPA.

Update #3 ·

Added: Oct 08, 2015 9:46 am Competitively awarded basic research and development contract with goals, objectives, specifications that will attempt to prove the scientific or engineering concepts in question, with cost estimates that are insufficient to permit use of a fixed price contract. Also, the contract will not mature sufficiently to transition to a firm fixed price contract while the program is managed at DARPA.

Update #2 ·

Added: Jan 28, 2015 4:11 pm MODIFICATION 1 - The purpose of Modification 1 to DARPA-BAA-15-06, the Electrical Prescriptions (ElectRx) Broad Agency Announcement, is to clarify the FAQ location.


DARPA will post a consolidated question and answer document (FAQ) to http://www.darpa.mil/Opportunities/Solicitations/BTO_Solicitations.aspx. Submit your question/s by E-mail to DARPA-BAA-15-06@darpa.mil. In order to receive a response, send your question/s by 13 February 2015.

Update #1 ·

Added: Dec 11, 2014 1:05 pm  

The DARPA ElectRx program seeks innovative research proposals for creating closed-loop neuromodulation systems that utilize innate neurophysiological circuits to achieve therapeutic benefits. To achieve this goal, ElectRx will simultaneously drive biological understanding and technology development. Specifically, ElectRx is looking to develop and leverage fundamental understanding of the anatomy and physiology of neural circuits in the spinal cord or peripheral nerves that mediate health status.  This knowledge will be leveraged to design and demonstrate feedback-controlled neuromodulation systems for the direct regulation of immune system functions and CNS disorders. In parallel, technology development focused on next-generation minimally-invasive neural interfaces and biosensors will enable interaction with the neurophysiology of interest at unmatched spatiotemporal resolution, precision, and specificity. These neuromodulation treatments will be tuned automatically and continuously to the unique physiology of each individual and will produce no off-target effects.  Additional information set forth in attached BAA.

Attachments

Files attached to this notice, newest first
File Type Posted
Attachment_4_-_DARPA-BAA-15-06_-_SOW_Template.docx DOCX document
Attachment_3_-_DARPA-BAA-15-06_-_Budget_Template.xlsx XLSX spreadsheet
DARPA-BAA-15-06_-_ElectRx_FINAL.docx DOCX document
Attachment_1_-_DARPA-BAA-15-06_-_Proposer_Checklist.pdf PDF
Attachment_2_-_DARPA-BAA-15-06_-_Proposal_Slide_Template.pptx PPTX presentation

Notice history

Notices posted for this opportunity, newest first
Notice Type Posted
Electrical Prescriptions Latest Award Notice
Electrical Prescriptions (ElectRx) This notice · Original Award Notice

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity